Liquidia Corp Contracts & Agreements

First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on November 13, 2024)

Device License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on November 13, 2024)

Fifth Amendment to Revenue Interest Financing Agreement, dated as of September 11, 2024, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Filed With SEC on September 12, 2024)

Registration Rights Agreement by and among Liquidia Corporation and the Purchasers, dated September 10, 2024 (Filed With SEC on September 12, 2024)

Common Stock Purchase Agreement by and among Liquidia Corporation and the Purchasers, dated September 10, 2024 (Filed With SEC on September 12, 2024)

Underwriting Agreement by and between Liquidia Corporation and BofA Securities, Inc., as representative of the underwriters named therein, dated September 11, 2024 (Filed With SEC on September 12, 2024)

Liquidia Corporation Amended and Restated Executive Severance and Change in Control Plan (Filed With SEC on May 14, 2024)

License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on March 13, 2024)

Description of Securities of the Company (Filed With SEC on March 13, 2024)

Liquidia Corporation 2020 Long-Term Incentive Plan (Filed With SEC on March 13, 2024)

Form of Restricted Stock Units Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan (Filed With SEC on March 13, 2024)

Form of Restricted Stock Units Agreement (Performance-Based) under the Liquidia Corporation 2020 Long-Term Incentive Plan (Filed With SEC on March 13, 2024)

Form of Incentive Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan (Filed With SEC on March 13, 2024)

Form of Non-Qualified Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan (Filed With SEC on March 13, 2024)

Second Amendment to Revenue Interest Financing Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Filed With SEC on March 13, 2024)

Third Amendment to Revenue Interest Financing Agreement, dated as of July 27, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Filed With SEC on March 13, 2024)

Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated July 13, 2023, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC (Filed With SEC on March 13, 2024)

Supply Agreement, dated May 22, 2023, by and between Liquidia Technologies, Inc. and Plastiape SpA (Filed With SEC on March 13, 2024)

Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on March 13, 2024)

Registration Rights Agreement, dated as of January 4, 2024, by and between Liquidia Corporation and the Purchaser (Filed With SEC on January 8, 2024)

Fourth Amendment to Revenue Interest Financing Agreement, dated as of January 3, 2024, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Filed With SEC on January 8, 2024)

Common Stock Purchase Agreement, dated as of January 4, 2024, by and between Liquidia Corporation and the Purchaser (Filed With SEC on January 8, 2024)

Purchase Agreement by and between Liquidia Corporation and Roger Jeffs, dated December 12, 2023 (Filed With SEC on December 14, 2023)

Underwriting Agreement by and between Liquidia Corporation and BofA Securities, Inc., as representative of the underwriters named therein, dated December 12, 2023 (Filed With SEC on December 14, 2023)

Liquidia Corporation Policy for Recovery of Erroneously Awarded Incentive Compensation (Filed With SEC on November 7, 2023)

Third Amendment to Revenue Interest Financing Agreement, dated as of July 27, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Filed With SEC on August 10, 2023)

Second Amendment to Revenue Interest Financing Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P (Filed With SEC on August 10, 2023)

License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on August 10, 2023)

Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on August 10, 2023)

Supply Agreement, dated May 22, 2023, by and between Liquidia Technologies, Inc. and Plastiape SpA (Filed With SEC on August 10, 2023)

Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated July 13, 2023, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC (Filed With SEC on August 10, 2023)

First Amendment to Revenue Interest Financing Agreement, dated as of April 17, 2023, by and among Liquidia Technologies, Inc., Healthcare Royalty Partners IV, L.P., and HCR... (Filed With SEC on May 8, 2023)

Research License Agreement, dated as of March 31, 2023, by and between Liquidia Technologies, Inc. and Glaxo Group Limited (Filed With SEC on May 8, 2023)

Fourth Amendment to Promotion Agreement, dated as of March 10, 2023, by and between Liquidia PAH, LLC and Sandoz Inc (Filed With SEC on May 8, 2023)

Severance Agreement and General Release, dated as of June 28, 2022, by and between Liquidia Technologies, Inc. and Tushar Shah, M.D (Filed With SEC on July 1, 2022)

Executive Employment Agreement, dated as of June 13, 2022, by and between Liquidia Technologies, Inc. and Rajeev Saggar (Filed With SEC on June 22, 2022)

Amendment to 2020 Long-Term Incentive Plan (Filed With SEC on June 17, 2022)

Underwriting Agreement by and between Liquidia Corporation and BofA Securities, Inc., as representative of the underwriters named therein, dated April 12, 2022 (Filed With SEC on April 18, 2022)

Commercial Manufacturing Services and Supply Agreement, dated November 12, 2020, by and between Liquidia Technologies, Inc. and Xcelience, LLC (Filed With SEC on March 17, 2022)

LIQ861 API Supply Agreement, dated as of January 10, 2020, by and among LGM Pharma LLC, Yonsung Fine Chemicals Co. Ltd. and Liquidia Technologies, Inc (Filed With SEC on March 17, 2022)

Amendment No. 1 to the Liquidia Corporation 2020 Employee Stock Purchase Plan (Filed With SEC on March 17, 2022)

Separation Agreement and General Release, dated as of January 31, 2022, by and between Liquidia Technologies, Inc. and Damian deGoa (Filed With SEC on February 4, 2022)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2022 Inducement Plan (Filed With SEC on January 31, 2022)

Liquidia Corporation 2022 Inducement Plan (Filed With SEC on January 31, 2022)

Amended and Restated Loan and Security Agreement, dated as of January 7, 2022, by and among the Company, Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P (Filed With SEC on January 11, 2022)

Warrant to Purchase Stock, dated as of January 7, 2022, by and between the Company and Innovation Credit Fund VIII-A L.P (Filed With SEC on January 11, 2022)

Warrant to Purchase Stock, dated as of January 7, 2022, by and between the Company and SVB Innovation Credit Fund VIII, L.P (Filed With SEC on January 11, 2022)

Warrant to Purchase Stock, dated as of January 7, 2022, by and between the Company and Silicon Valley Bank (Filed With SEC on January 11, 2022)

Executive Employment Agreement, dated as of January 3, 2022, by and between Liquidia Corporation and Roger A. Jeffs, Ph.D (Filed With SEC on January 4, 2022)

First Loan Modification Agreement, dated as of August 26, 2021, by and among Silicon Valley Bank, Liquidia Corporation, Liquidia Technologies, Inc. and Liquidia PAH, LLC (Filed With SEC on August 30, 2021)

Standstill Agreement, dated as of April 13, 2021, by and among Liquidia Corporation and Caligan Partners LP (Filed With SEC on April 13, 2021)

Registration Rights Agreement, dated as of April 12, 2021, by and among Liquidia Corporation and the Purchasers (Filed With SEC on April 13, 2021)

Common Stock Purchase Agreement, dated as of April 12, 2021, by and among Liquidia Corporation and the Purchasers (Filed With SEC on April 13, 2021)

Liquidia Corporation Executive Severance and Change in Control Plan (Filed With SEC on March 25, 2021)

Executive Employment Agreement, dated as of May 18, 2020, by and between Liquidia Technologies, Inc. and Tushar Shah (Filed With SEC on March 25, 2021)

Liquidia Corporation 2020 Long-Term Incentive Plan, and forms of award agreements thereunder (Filed With SEC on March 25, 2021)

Description of Securities of the Company (Filed With SEC on March 25, 2021)

Warrant to Purchase Stock, issued February 26, 2021, by Liquidia Corporation to Silicon Valley Bank (Filed With SEC on March 3, 2021)

Loan and Security Agreement, dated as of February 26, 2021, by and among Silicon Valley Bank, Liquidia Corporation, Liquidia Technologies, Inc. and Liquidia PAH, LLC (Filed With SEC on March 3, 2021)

Severance Agreement and General Release, dated as of January 13, 2021, by and between Liquidia Technologies, Inc. and Neal F. Fowler (Filed With SEC on January 14, 2021)

Nonstatutory Stock Option Agreement, dated as of December 15, 2020, by and between Liquidia Corporation and Damian deGoa (Filed With SEC on December 16, 2020)

Executive Employment Agreement, dated as of December 14, 2020, by and between Liquidia Technologies, Inc. and Damian deGoa (Filed With SEC on December 16, 2020)

Executive Employment Agreement, dated as of November 30, 2020, by and between Liquidia Technologies, Inc. and Michael Kaseta (Filed With SEC on December 1, 2020)

Liquidia Corporation Executive Severance and Change in Control Plan (Filed With SEC on August 5, 2020)

Form of Specimen Common Stock Certificate of Liquidia Corporation (Filed With SEC on August 5, 2020)

Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Neal F. Fowler, dated as of June 29, 2020 (Filed With SEC on August 5, 2020)

Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Canaan VIII L.P., dated as of June 29, 2020 (Filed With SEC on August 5, 2020)

Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and Eshelman Ventures, LLC and Fredric N. Eshelman, dated as of June 29, 2020 (Filed With SEC on August 5, 2020)

Support Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., RareGen, LLC and New Enterprise Associates 12, Limited Partnership and NEA Ventures 2006 Limited... (Filed With SEC on August 5, 2020)

Cooperation Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc., PBM Capital Finance, LLC and PD Joint Holdings, LLC Series 2016-A, dated as of June 29, 2020 (Filed With SEC on August 5, 2020)

Cooperation Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc. and Serendipity BioPharma LLC, dated as of June 29, 2020 (Filed With SEC on August 5, 2020)

Form of Lock-Up Agreement by and among Liquidia Corporation, Liquidia Technologies, Inc. and each of the RareGen members party thereto (Filed With SEC on August 5, 2020)

Joinder and Second Amendment to Amended and Restated Loan and Security Agreement, effective as of July 3, 2020, by and among Liquidia Corporation, Gemini Merger Sub I, Inc.,... (Filed With SEC on August 5, 2020)

Liquidia Corporation Annual Cash Bonus Plan (Filed With SEC on August 5, 2020)

Promotion Agreement, dated as of August 1, 2018, by and between RareGen, LLC and Sandoz Inc (Filed With SEC on August 5, 2020)

First Amendment to Promotion Agreement, effective as of May 8, 2020, by and between RareGen, LLC and Sandoz Inc (Filed With SEC on August 5, 2020)

Form of Litigation Funding and Indemnification Agreement, by and between RareGen, LLC and PBM RG Holdings, LLC (Filed With SEC on August 5, 2020)

Joint Development Agreement, dated May 6, 2019, between RareGen, LLC and Carelife USA Inc (Filed With SEC on August 5, 2020)

Limited Waiver and Modification to Agreement and Plan of Merger, dated as of August 3, 2020, by and among Liquidia Technologies, Inc., RareGen, LLC, Liquidia Corporation, Gemini... (Filed With SEC on August 5, 2020)

Category

Industry

Companies

Contracts

Liquidia Corp Contracts & Agreements